Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Austin TX, Houston TX, New York NY,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06167317
Phase 1, Recruiting
Study of APR-1051 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Irving TX, San Antonio TX, Houston TX, Cleveland OH,
Sponsor: Aprea Therapeutics
Sex: All
Age: 18+
Code: NCT06260514
Phase 1, Recruiting
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX, Grand Rapids MI,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06804824
Phase 1, Recruiting
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
for
Cancer
Location: Irving TX, Austin TX, Aurora CO, Atlanta GA, Chicago IL,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT06014658
Phase 1, Phase 2, Recruiting
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Irving TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06589596
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Location: Irving TX, Oklahoma City OK, Houston TX, Westwood KS,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06445062
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors